Heidi Nelson to Neoplasms
This is a "connection" page, showing publications Heidi Nelson has written about Neoplasms.
Connection Strength
6.592
-
Quality of Cancer Recurrence Data in the National Cancer Database: A Reappraisal of Reporting Readiness. Ann Surg Oncol. 2025 Mar; 32(3):1553-1564.
Score: 0.642
-
ASO Visual Abstract: National Cancer Database Conforms with Standardized Framework for Registry and Data Quality. Ann Surg Oncol. 2024 Sep; 31(9):5589-5590.
Score: 0.627
-
ASO Author Reflections: The Commission on Cancer's Role in Quality Procedures that Govern the National Cancer Database. Ann Surg Oncol. 2024 Sep; 31(9):5585-5586.
Score: 0.614
-
The National Cancer Database Conforms to the Standardized Framework for Registry and Data Quality. Ann Surg Oncol. 2024 Sep; 31(9):5546-5559.
Score: 0.613
-
Renovating the Commission on Cancer's Quality Measure Portfolio. Ann Surg. 2024 Aug 01; 280(2):193-198.
Score: 0.609
-
Digital Cancer Care and the Vision for Transforming the Quality of Care. J Registry Manag. 2024; 51(3):104-108.
Score: 0.599
-
National Cancer Database Reports Ongoing Disruptions in Cancer Diagnoses in 2021. Ann Surg Oncol. 2024 Feb; 31(2):729-730.
Score: 0.596
-
Twenty-Five Years of Cancer Follow-Up; Is the Data Worth the Effort? Ann Surg Oncol. 2022 Feb; 29(2):828-836.
Score: 0.515
-
Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014. Ann Surg Oncol. 2019 Jun; 26(6):1604-1612.
Score: 0.426
-
First National Effort to Optimize the Performance of Cancer Surgery by the American College of Surgeons Commission on Cancer and Cancer Surgery Standards Program: Early Results After Implementation of the Operative Standards. Ann Surg. 2025 Sep 01; 282(3):371-381.
Score: 0.165
-
Cancer Survivorship Care in the United States at Facilities Accredited by the Commission on Cancer. JAMA Netw Open. 2024 Jul 01; 7(7):e2418736.
Score: 0.155
-
Alterations in Cancer Treatment During the First Year of the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 10 02; 6(10):e2340148.
Score: 0.147
-
Disruption of National Cancer Database Data Models in the First Year of the COVID-19 Pandemic. JAMA Surg. 2023 06 01; 158(6):643-650.
Score: 0.144
-
Letter to the Editor: Re: Reimagining Cancer Staging in the Era of Evolutionary Oncology. J Natl Compr Canc Netw. 2023 04; 21(4):xviii.
Score: 0.142
-
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening. JAMA Netw Open. 2022 11 01; 5(11):e2242354.
Score: 0.138
-
Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation. JAMA Netw Open. 2021 07 01; 4(7):e2115675.
Score: 0.126
-
Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Netw Open. 2020 05 01; 3(5):e203942.
Score: 0.116
-
Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26(13):4213-4221.
Score: 0.112
-
Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group. Ann Surg Oncol. 2011 Dec; 18(13):3544-50.
Score: 0.063
-
Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer. 2006 Jan 01; 106(1):188-95.
Score: 0.043